UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives

European journal of medicinal chemistry, 2016-02, Vol.109, p.314-341

2016

Link zum Volltext

Verfügbarkeit prüfen

PIM kinase inhibitors: Structural and pharmacological perspectives

European journal of medicinal chemistry, 2019-06, Vol.172, p.95-108

2019

Link zum Volltext

Verfügbarkeit prüfen

Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives

Current topics in medicinal chemistry, 2017-11, Vol.17 (28), p.3146

2017

Link zum Volltext

Verfügbarkeit prüfen

1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents

European journal of medicinal chemistry, 2015-06, Vol.97, p.124-141

2015

Link zum Volltext

Verfügbarkeit prüfen

K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives

European journal of medicinal chemistry, 2017-01, Vol.125, p.299-314

2017

Link zum Volltext

Verfügbarkeit prüfen

Structural Aspects of mTOR Inhibitors: Search for Potential Compounds

Anti-cancer agents in medicinal chemistry, 2022-04, Vol.22 (6), p.1037

2022

Link zum Volltext

Verfügbarkeit prüfen

An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent

European journal of medicinal chemistry, 2020-10, Vol.204, p.112523-112523, Article 112523

2020

Link zum Volltext

Verfügbarkeit prüfen

Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies

Current pharmaceutical design, 2016-01, Vol.22 (39), p.6039

2016

Link zum Volltext

Verfügbarkeit prüfen

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy

1, 2024

Link zum Volltext

Verfügbarkeit prüfen

Inhibition performances of new pyrazole derivatives against the corrosion of C38 steel in acidic medium: Computational study

Results in surfaces and interfaces, 2024-02, Vol.14, p.100184, Article 100184

2024

Link zum Volltext

Verfügbarkeit prüfen

Mutant B-Raf Kinase Inhibitors as Anticancer Agents

Anti-cancer agents in medicinal chemistry, 2016-01, Vol.16 (12), p.1558

2016

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, characterization and antimicrobial evaluation of some 1,3-benzothiazole-2-yl-hydrazone derivatives

Arabian journal of chemistry, 2015-07, Vol.8 (4), p.495-499

2015

Link zum Volltext

Verfügbarkeit prüfen

Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives

European journal of medicinal chemistry, 2015-03, Vol.92, p.839-865

2015

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis and molecular modeling studies of novel thiazolidine-2,4-dione derivatives as potential anti-cancer agents

Journal of molecular structure, 2018-02, Vol.1154, p.406-417

2018

Link zum Volltext

Verfügbarkeit prüfen

Chalcone scaffolds as anti-infective agents: Structural and molecular target perspectives

European journal of medicinal chemistry, 2015-08, Vol.101, p.496-524

2015

Link zum Volltext

Verfügbarkeit prüfen

3D-QSAR and Molecular Docking Studies on Oxadiazole Substituted Benzimidazole Derivatives: Validation of Experimental Inhibitory Potencies Towards COX-2

Current computer-aided drug design, 2019-01, Vol.15 (4), p.277

2019

Link zum Volltext

Verfügbarkeit prüfen

Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications

European journal of medicinal chemistry, 2019-07, Vol.174, p.142-158

2019

Link zum Volltext

Verfügbarkeit prüfen

Anti-cancer chalcones: Structural and molecular target perspectives

European journal of medicinal chemistry, 2015-06, Vol.98, p.69-114

2015

Link zum Volltext

Verfügbarkeit prüfen

Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches

European journal of medicinal chemistry, 2021-12, Vol.225, p.113781, Article 113781

2021

Link zum Volltext

Verfügbarkeit prüfen

Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents

European journal of medicinal chemistry, 2014-11, Vol.87, p.814-833

2014

Link zum Volltext

Verfügbarkeit prüfen

Unveiling the promise of pyrimidine-modified CDK inhibitors in cancer treatment

Bioorganic chemistry, 2024-08, Vol.149, p.107508, Article 107508

2024

Link zum Volltext

Verfügbarkeit prüfen

Integrated fragment-based drug design and virtual screening techniques for exploring the antidiabetic potential of thiazolidine-2,4-diones: Design, synthesis and in vivo studies

European journal of medicinal chemistry, 2023-12, Vol.261, p.115826-115826, Article 115826

2023

Link zum Volltext

Verfügbarkeit prüfen

Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer

Molecular diversity, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Combined computational and synthetic strategies for the development of potent pyrazolo-pyridine derivatives as anticancer agents

Journal of molecular structure, 2024-09, Vol.1311, p.138301, Article 138301

2024

Link zum Volltext

Verfügbarkeit prüfen

Identification of potential N-substituted 5-benzylidenethiazolidine-2,4‑dione derivatives as α-amylase inhibitors: Computational cum synthetic studies

Journal of molecular structure, 2023-09, Vol.1287, p.135596, Article 135596

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(79)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(33)
Pharmacology & Pharmacy
(26)
Chemistry, Medicinal
(24)
Chemistry
(21)
Physical Sciences
(21)
Humans
(19)
Pharmacology
(11)
Antineoplastic Agents - Pharmacology
(10)
Cancer
(10)
Antineoplastic Agents - Chemistry
(9)
Biochemistry & Molecular Biology
(9)
Chemistry, Physical
(9)
Docking
(8)
Inhibitors
(8)
Organic Chemistry
(8)
Structure-Activity Relationship
(7)
Thiazolidine-2,4-Dione
(7)
Anticancer
(6)
Chalcone
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives

PIM kinase inhibitors: Structural and pharmacological perspectives

Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives

1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents

K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives

Structural Aspects of mTOR Inhibitors: Search for Potential Compounds

An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent

Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy

Inhibition performances of new pyrazole derivatives against the corrosion of C38 steel in acidic medium: Computational study

Mutant B-Raf Kinase Inhibitors as Anticancer Agents

Synthesis, characterization and antimicrobial evaluation of some 1,3-benzothiazole-2-yl-hydrazone derivatives

Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives

Design, synthesis and molecular modeling studies of novel thiazolidine-2,4-dione derivatives as potential anti-cancer agents

Chalcone scaffolds as anti-infective agents: Structural and molecular target perspectives

3D-QSAR and Molecular Docking Studies on Oxadiazole Substituted Benzimidazole Derivatives: Validation of Experimental Inhibitory Potencies Towards COX-2

Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications

Anti-cancer chalcones: Structural and molecular target perspectives

Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches

Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents

Unveiling the promise of pyrimidine-modified CDK inhibitors in cancer treatment

Integrated fragment-based drug design and virtual screening techniques for exploring the antidiabetic potential of thiazolidine-2,4-diones: Design, synthesis and in vivo studies

Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer

Combined computational and synthetic strategies for the development of potent pyrazolo-pyridine derivatives as anticancer agents

Identification of potential N-substituted 5-benzylidenethiazolidine-2,4‑dione derivatives as α-amylase inhibitors: Computational cum synthetic studies

Suchergebnisse filtern